Company Profile
Sophia Genetics Stock Price, News & Analysis
- Ticker:
- SOPH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Switzerland
Stock performance
6.30 USD (-7.89%)
Close
Last updated: August 5, 2026
355M USD
Market cap
Why the stock is moving
As of Aug 5, 2026, SOPH closed down 7.89% at $6.30. No new same-company headline was identified in the current news window.
Company overview
Business overview
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support. Its business is centered on applying software to genomic and pathology workflows.
Geographic Base and Sector Classification
Headquartered in Switzerland and listed on NASDAQ as an ADR, Sophia Genetics sits in healthcare data and diagnostics.
Business Model Characteristics
The company depends on software adoption, diagnostics workflows, and the value of its data platform across hospitals and labs.
Position Within the Biotechnology Landscape
Sophia Genetics is outside biotech proper and belongs to the diagnostics software layer.
Future catalysts
SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue. The business improves when the analytics workflow becomes more embedded in clinical and biopharma use cases.
Recent news
- 01
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
Source: Sophia Genetics
- 02
SOPHiA GENETICS Reports First Quarter 2024 Results
Source: Sophia Genetics
- 03
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Source: Sophia Genetics
- 04
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
Source: Sophia Genetics
- 05
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
Source: Sophia Genetics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sophia Genetics (SOPH)?
Sophia Genetics (SOPH) most recently closed at 6.30 USD, a -7.89% move versus the previous session.
What is the market cap of Sophia Genetics (SOPH)?
Sophia Genetics currently has a market capitalization of 355M USD on BioPharmSignal.
What does Sophia Genetics do?
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support. Its business is centered on applying software to genomic and pathology workflows.
On which exchange is SOPH stock listed?
Sophia Genetics (SOPH) is associated with NASDAQ, Switzerland, Biopharma.
What is Sophia?
SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue.
Which conditions is Sophia Genetics targeting with Sophia?
Sophia Genetics is associated with genetic disease based on its company overview and current catalyst commentary.
How does Sophia Genetics describe recent progress with Sophia?
SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue.
What is Genetics?
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support.